Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies.
Janakiram, Murali
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies. [electronic resource] - Immunotherapy 06 2016 - 809-19 p. digital
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
1750-7448
10.2217/imt-2016-0001 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Costimulatory and Inhibitory T-Cell Receptors--immunology
Hematologic Neoplasms--immunology
Humans
Immunologic Memory
Lung Neoplasms--immunology
Treatment Outcome
Tumor Escape
Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies. [electronic resource] - Immunotherapy 06 2016 - 809-19 p. digital
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
1750-7448
10.2217/imt-2016-0001 doi
Animals
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents--therapeutic use
Costimulatory and Inhibitory T-Cell Receptors--immunology
Hematologic Neoplasms--immunology
Humans
Immunologic Memory
Lung Neoplasms--immunology
Treatment Outcome
Tumor Escape